ImmunoGen, Inc.
USD31.23
+0.01 (+0.02%)
CEO
Mark Joseph Enyedy
IPO Date
1989-11-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$31.24
Prev. Close
$31.23
Day Low
$31.22
Day High
$31.25
52W Low
$3.61
52W High
$31.25
Market Cap
$8.73B
Volume
19.31M
| -11.0 |
| 31 Dec 2020 | FY | 13.4% | -50.4% | -74.4% | -18.8% | 0.27 | 2.40 | -17.0 |
| 31 Dec 2019 | FY | -39.2% | -148.4% | 160.4% | -51.8% | -0.35 | 2.28 | -6.2 |
| 31 Dec 2018 | FY | -223.1% | -311.9% | -1405.7% | -56.8% | 0.17 | 3.74 | -4.0 |
| 31 Dec 2017 | FY | -21.0% | -83.2% | 536.5% | -32.6% | -0.11 | 4.79 | -6.5 |
| 31 Dec 2016 | FY | -190.6% | -322.3% | 102.5% | -78.8% | 0.00 | 3.16 | -1.1 |
| 30 Jun 2016 | FY | -144.9% | -239.4% | 177.0% | -50.0% | -1.23 | 4.06 | -1.9 |
| 30 Jun 2015 | FY | -30.7% | -71.0% | -173.0% | -19.4% | 0.00 | 7.77 | -20.4 |
| 30 Jun 2014 | FY | -78.6% | -119.1% | -94.3% | -43.2% | 0.00 | 6.69 | -14.2 |
| -292.6 |
| 31 Mar 2023 | Q1 | 98.7% | -81.3% | -33.3% | -14.1% | 0.12 | 1.98 | -6.1 |
| 31 Dec 2022 | Q4 | 99.6% | -143.3% | -37.9% | -16.9% | 0.10 | 2.26 | -5.3 |
| 30 Sept 2022 | Q3 | 97.2% | -507.8% | -43.9% | -21.8% | 0.09 | 3.19 | -3.8 |
| 30 Jun 2022 | Q2 | 100.0% | -444.8% | -25.2% | -14.9% | 0.07 | 4.29 | -4.5 |
| 31 Mar 2022 | Q1 | 100.0% | -66.8% | -8.3% | -5.3% | 0.06 | 5.43 | -11.8 |
| 31 Dec 2021 | Q4 | -22.9% | -132.8% | -11.4% | -7.1% | 0.06 | 4.74 | -10.5 |
| 30 Sept 2021 | Q3 | 100.0% | -405.4% | -48.4% | -12.6% | 0.25 | 2.20 | -7.8 |
| 30 Jun 2021 | Q2 | 100.0% | -181.4% | -44.9% | -10.2% | 0.31 | 1.99 | -10.7 |